astrazeneca
There are 18 repositories under astrazeneca topic.
MolecularAI/aizynthfinder
A tool for retrosynthetic planning
MolecularAI/REINVENT4
AI molecular design tool for de novo design, scaffold hopping, R-group replacement, linker design and molecule optimization.
MolecularAI/DockStream
DockStream: A Docking Wrapper to Enhance De Novo Molecular Design
MolecularAI/route-distances
Tools and routines to calculate distances between synthesis routes and to cluster them.
MolecularAI/Siamese-RNN-Self-Attention
Contains code for Siamese Recurrent Neural Network with Self-Attention for Bioactivity Prediction
BDelacour/DoctolibChecker
Track available dose of covid-19 vaccine on Doctolib using a list of centers. Alerts the user via a Telegram notification
thelostvoice/global-takeover
The COVID graphene-based injections are their weapons for global assimilation and eventual replacement of the human race
EliseoBaquero/Italy_vaccination_campaign
Analysis of Italy vaccination campaign of covid-19 in 2021, the italian government got four diffenrent types of vaccines to protect the population,
c-vandenberg/aizynthfinder-seq2seq-transformer
Research project and literature review focused on integrating SMILES-based retrosynthesis using sequence-to-sequence (Seq2Seq) and transformer models into AstraZeneca’s AiZynthFinder retrosynthetic planning tool.
ChristianJP/GreatUniHack-AstraZeneca1stPlace-
Winning 1st Place Entry for Great Uni Hack - PlantMedic an app for tracking your own plants and public plants allowing you to plan walks to visit plants aswell as a built in API for Image recognition of plants. Walk outside more! Feel Better :)
finxol/prestomadose
Outil de recherche automatisée de rendez-vous vaccination COVID-19
sawsanowa/Sentiment-Analysis-of-COVID-19-Vaccination-in-Saudi-Arabia
Studying people perception regarding COVID-19 vaccination in Saudi Arabia during selected events
MahanPourhosseini/Novartis-Financial-Analysis
This repository contains a comprehensive financial analysis of Novartis from 2019 to 2023, benchmarked against AstraZeneca and Roche. Conducted as part of the Accounting, Finance & Control course at Politecnico di Milano, this project was completed during the first semester of the 2024/2025 academic year (A.Y.).